Oculis Holding AG (OCS) Cash from Investing Activities (2022 - 2024)
Oculis Holding AG (OCS) recorded quarterly Cash from Investing Activities of -$19.7 million in Q2 2024, down 738.58% quarter-over-quarter from -$2.3 million in Q1 2024.
Oculis Holding AG (OCS) Cash from Investing Activities (2022 - 2024) Analysis & Trends
Oculis Holding AG's Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$19.7 million for Q2 2024.
- In Q2 2024, Cash from Investing Activities changed N/A year-over-year to -$19.7 million; the TTM figure through Jun 2024 stood at -$464875.5 (changed N/A YoY), while the FY2025 annual figure was -$76.2 million, down 315.26% from the prior year.
- Cash from Investing Activities was -$19.7 million for Q2 2024 at Oculis Holding AG, down from -$2.3 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $25.9 million in Q4 2023 to a low of -$19.7 million in Q2 2024.
- Historically, Cash from Investing Activities has averaged -$427938.7 across 3 years, with a median of -$2.0 million in 2024.
- Biggest YoY gain for Cash from Investing Activities was 1744.57% in 2023; the steepest drop was 714.06% in 2023.
- A 3-year view of Cash from Investing Activities shows it stood at -$1.6 million in 2022, then jumped by 1744.57% to $25.9 million in 2023, then tumbled by 176.04% to -$19.7 million in 2024.
- The last three Cash from Investing Activities figures came in at -$19.7 million (Q2 2024), -$2.3 million (Q1 2024), and $25.9 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 579,519.10 |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -19.67 Mn |
| Jun 30, 2024 | -19.67 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | 25.86 Mn |
| Dec 31, 2023 | 25.86 Mn |
| Sep 30, 2023 | -4.32 Mn |
| Sep 30, 2023 | -4.32 Mn |
| Dec 31, 2022 | -1.57 Mn |
| Dec 31, 2022 | -1.57 Mn |
| Sep 30, 2022 | -530,153.80 |
| Sep 30, 2022 | -530,153.80 |